These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 11699612
21. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients. Zhang XQ, Wang ZW, Fan JW, Li YP, Jiao Z, Gao JW, Peng ZH, Liu GL. Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746 [Abstract] [Full Text] [Related]
22. Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantation. Fukudo M, Yano I, Fukatsu S, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K. Clin Pharmacokinet; 2003 Apr; 42(13):1161-78. PubMed ID: 14531726 [Abstract] [Full Text] [Related]
23. Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. Staatz CE, Taylor PJ, Lynch SV, Willis C, Charles BG, Tett SE. Transplantation; 2001 Sep 27; 72(6):1056-61. PubMed ID: 11579300 [Abstract] [Full Text] [Related]
25. Pharmacokinetics and Pharmacodynamics of Once-Daily Tacrolimus Compared With Twice-Daily Tacrolimus in the Early Stage After Living Donor Liver Transplantation. Iwasaki M, Yano I, Fukatsu S, Hashi S, Yamamoto Y, Sugimoto M, Fukudo M, Masuda S, Nakagawa S, Yonezawa A, Kaido T, Uemoto S, Matsubara K. Ther Drug Monit; 2018 Dec 27; 40(6):675-681. PubMed ID: 29965882 [Abstract] [Full Text] [Related]
26. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients. Prytuła AA, Cransberg K, Bouts AH, van Schaik RH, de Jong H, de Wildt SN, Mathôt RA. Clin Pharmacokinet; 2016 Sep 27; 55(9):1129-43. PubMed ID: 27138785 [Abstract] [Full Text] [Related]
28. High Variability of Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation. Sikma MA, Hunault CC, Van Maarseveen EM, Huitema ADR, Van de Graaf EA, Kirkels JH, Verhaar MC, Grutters JC, Kesecioglu J, De Lange DW. Eur J Drug Metab Pharmacokinet; 2020 Feb 27; 45(1):123-134. PubMed ID: 31745812 [Abstract] [Full Text] [Related]
33. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients. Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y. Clin Pharmacokinet; 2004 Jan 27; 43(11):741-62. PubMed ID: 15301578 [Abstract] [Full Text] [Related]
34. Population pharmacokinetics of mizoribine in adult recipients of renal transplantation. Ishida K, Okamoto M, Ishibashi M, Hashimoto Y. Clin Exp Nephrol; 2011 Dec 27; 15(6):900-6. PubMed ID: 21751083 [Abstract] [Full Text] [Related]
35. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance. Wallin JE, Bergstrand M, Wilczek HE, Nydert PS, Karlsson MO, Staatz CE. Ther Drug Monit; 2011 Dec 27; 33(6):663-72. PubMed ID: 22105583 [Abstract] [Full Text] [Related]
36. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients. Benkali K, Prémaud A, Picard N, Rérolle JP, Toupance O, Hoizey G, Turcant A, Villemain F, Le Meur Y, Marquet P, Rousseau A. Clin Pharmacokinet; 2009 Dec 27; 48(12):805-16. PubMed ID: 19902988 [Abstract] [Full Text] [Related]
37. Pharmacokinetics of tacrolimus in liver transplant patients. Jusko WJ, Piekoszewski W, Klintmalm GB, Shaefer MS, Hebert MF, Piergies AA, Lee CC, Schechter P, Mekki QA. Clin Pharmacol Ther; 1995 Mar 27; 57(3):281-90. PubMed ID: 7535213 [Abstract] [Full Text] [Related]